Trademark: 97131763
Word
IWILFIN
Status Date
Thursday, January 18, 2024
Filing Date
Thursday, November 18, 2021
Published for Opposition
Tuesday, May 24, 2022
5 Pharmaceuticals for the treatment and prevention of cancer; Pharmaceuticals for use in conjunction with multi-modal therapies for treatment of neuroblastoma
35 Promoting public awareness of the need for research for the diagnosis, treatment, and development of a cure for childhood cancer, in particular pediatric neuroblastoma
The mark consists of The word "IWILFIN" in lower case letters the left and adjacent to three interlocking quadrilaterals angled to the right.
Color is not claimed as a feature of the mark.
Jan 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 18, 2024
Sou Extension 3 Granted
Jan 18, 2024
Sou Extension 3 Filed
Jan 18, 2024
Sou Teas Extension Received
Oct 22, 2023
Teas Change Of Correspondence Received
Oct 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2023
Sou Extension 2 Granted
Jun 29, 2023
Sou Extension 2 Filed
Jun 29, 2023
Sou Teas Extension Received
Jan 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2023
Sou Extension 1 Granted
Jan 5, 2023
Sou Extension 1 Filed
Jan 5, 2023
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 15, 2022
Approved For Pub - Principal Register
Apr 14, 2022
Assigned To Examiner
Nov 24, 2021
Notice Of Design Search Code E-Mailed
Nov 23, 2021
New Application Office Supplied Data Entered
Nov 22, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
